Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
77.97
+0.39 (+0.50%)
Streaming Delayed Price
Updated: 12:42 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Boston Scientific
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
June 14, 2024
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.
Via
Benzinga
Check Out What Whales Are Doing With BSX
June 07, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
June 03, 2024
Via
Benzinga
How Is The Market Feeling About Boston Scientific?
May 23, 2024
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
May 22, 2024
Via
Benzinga
Decoding 18 Analyst Evaluations For Boston Scientific
May 15, 2024
Via
Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
May 01, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Jim Cramer Recommends Buying This Sports Betting Company's Stock: 'I Think It's Terrific'
May 17, 2024
Sports betting app DraftKings is "terrific," Cramer says. The company recently reported Q1 revenue of $1.18 billion, up 53% year-over-year.
Via
Benzinga
Boston Scientific's Upside With Cardiology Devices Drives Momentum
May 15, 2024
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
Citi Just Raised Its Price Target on These 3 Stocks
May 04, 2024
Discover the three stocks enjoying boosted Citi price targets. Analysts believe they are primed for success, so it's time to start buying.
Via
InvestorPlace
Needham Just Boosted Its Price Target on These 3 Stocks
May 02, 2024
Amidst the uncertainty in the market at this time, it is best to rely on Needham price targets to make informed decisions.
Via
InvestorPlace
(BSX) - Analyzing Boston Scientific's Short Interest
April 25, 2024
Via
Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
April 25, 2024
Via
Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
April 26, 2024
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Via
Investor's Business Daily
Top 4 Health Care Stocks That May Plunge This Month
April 26, 2024
Via
Benzinga
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
April 25, 2024
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Via
Investor's Business Daily
Wabtec Rumbles onto Stock Spotlight List. Check These Lists For Best Stocks To Watch And Buy
April 24, 2024
Wabtec leads a diverse group climbing aboard the Stock Spotlight list, including defense and aerospace play TransDigm.
Via
Investor's Business Daily
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 24, 2024
Via
Benzinga
Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars
April 24, 2024
Boston Scientific reports impressive Q1 earnings, with revenues of $3.86 billion, beating estimates. Cardiovascular segment leads with $2.4 billion sales, up 15.9%. Outlook: 2024 net sales growth...
Via
Benzinga
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
April 24, 2024
Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the...
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
April 24, 2024
Via
Benzinga
BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024
April 24, 2024
BSX stock results show that Boston Scientific beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report
April 24, 2024
Boston Scientific heads for two different buy zones after topping Q1 views and hoisting guidance above expectations.
Via
Investor's Business Daily
Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally
April 24, 2024
Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m
Via
Benzinga
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
April 18, 2024
Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major...
Via
Benzinga
Exposures
Product Safety
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.
Via
Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
April 16, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.